Free Trial

Canopy Growth (TSE:WEED) Price Target Cut to C$3.20 by Analysts at ATB Capital

Canopy Growth logo with Medical background
Remove Ads

Canopy Growth (TSE:WEED - Free Report) had its price objective cut by ATB Capital from C$4.00 to C$3.20 in a report published on Monday morning,BayStreet.CA reports. They currently have an underperform rating on the stock.

Separately, Canaccord Genuity Group decreased their price objective on Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating for the company in a report on Monday. Four equities research analysts have rated the stock with a sell rating and one has given a hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Reduce" and an average price target of C$5.40.

Check Out Our Latest Analysis on Canopy Growth

Canopy Growth Price Performance

Shares of WEED stock remained flat at C$2.68 on Monday. The stock had a trading volume of 909,932 shares, compared to its average volume of 1,844,812. The stock has a market capitalization of C$431.13 million, a price-to-earnings ratio of -0.39, a P/E/G ratio of -0.01 and a beta of 1.79. The company's fifty day simple moving average is C$3.67 and its 200-day simple moving average is C$5.79. The company has a current ratio of 1.39, a quick ratio of 2.32 and a debt-to-equity ratio of 120.38. Canopy Growth has a fifty-two week low of C$2.50 and a fifty-two week high of C$20.50.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Further Reading

Analyst Recommendations for Canopy Growth (TSE:WEED)

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Quantum Stocks Are Heating Up Again — 7 to Watch Now

Quantum Stocks Are Heating Up Again — 7 to Watch Now

After a brief dip earlier this year, fresh momentum has reignited interest; from penny plays to tech giants, these quantum stocks could lead the next surge.

Related Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads